Theravance Biopharma, Inc. (TBPH)
USD 9.71
(-2.51%)
USD 9.71
(-2.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.99 Million | -186.99 Million | -207.85 Million | -250.4 Million | -238.19 Million | -112.86 Million |
| Net Income | -55.19 Million | -92.82 Million | -199.42 Million | -278.01 Million | -236.45 Million | -215.52 Million |
| Depreciation & Amortization | 4.25 Million | 7.02 Million | 9.7 Million | 9.06 Million | 6.21 Million | 3.16 Million |
| Deferred income taxes | 3.2 Million | - | -44.47 Million | 15.46 Million | - | -11.2 Million |
| Stock-based compensation | 25.37 Million | 39.73 Million | 62.06 Million | 62.97 Million | 60.45 Million | 51.31 Million |
| Change in working capital | -8.34 Million | 42.35 Million | -39.58 Million | -39.46 Million | -45.4 Million | 59.42 Million |
| Other non-cash items | 3.7 Million | -183.27 Million | 3.86 Million | -20.42 Million | -23 Million | -43 Thousand |
| Investing Cash Flow | -32.69 Million | 1.15 Billion | 124.49 Million | 10.72 Million | -83.05 Million | 176.7 Million |
| Investments in PPE | -2.48 Million | -572 Thousand | -3.4 Million | -6.61 Million | -3.17 Million | -7.24 Million |
| Acquisitions | 1.51 Million | 4.57 Million | 6000.00 | 64 Thousand | 5 Million | 20 Million |
| Investment purchases | -134.53 Million | -103.14 Million | -158.3 Million | -401.98 Million | -423.89 Million | -183.26 Million |
| Sales/Maturities of investments | 102.81 Million | 158.01 Million | 286.19 Million | 419.26 Million | 339.01 Million | 347.19 Million |
| Other Investing Activities | -30.2 Million | 1.09 Billion | 127.9 Million | 17.33 Million | 5000.00 | 17 Thousand |
| Financing Cash Flow | -198.93 Million | -758.8 Million | 91.86 Million | 263.08 Million | 1.29 Million | 225.2 Million |
| Debt repayment | - | -631.6 Million | -10.73 Million | -246.81 Million | -2.15 Million | -229.44 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -199.55 Million | -132.28 Million | -9.06 Million | -9.74 Million | -3.17 Million | -9.8 Million |
| Common Stock Issuance | 618 Thousand | 802 Thousand | 111.65 Million | 139.91 Million | 3.47 Million | 1.39 Million |
| Other Financing Activities | -2.5 Million | 5.07 Million | 111.65 Million | 764.79 Million | 3.14 Million | 235 Million |
| Accounts receivables | -689 Thousand | -2.72 Million | 1.8 Million | 6.12 Million | -11.32 Million | 1.63 Million |
| Accounts payables | 6000.00 | -1.61 Million | -3.53 Million | 3.65 Million | -4.27 Million | 3.57 Million |
| Inventory | -8.54 Million | - | -26.39 Million | -22.52 Million | 1.44 Million | -1.62 Million |
| Other working capital | 886 Thousand | 46.68 Million | -11.46 Million | -26.72 Million | -31.24 Million | 55.85 Million |
| Cash at beginning of period | 299 Million | 90.79 Million | 82.3 Million | 58.89 Million | 378.85 Million | 89.81 Million |
| Cash at end of period | 40.38 Million | 299 Million | 90.79 Million | 82.3 Million | 58.89 Million | 378.85 Million |
| Capital Expenditure | -2.48 Million | -572 Thousand | -3.4 Million | -6.61 Million | -3.17 Million | -7.24 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -258.62 Million | 208.21 Million | 8.49 Million | 23.4 Million | -319.95 Million | 289.04 Million |
| Free Cash Flow | -29.48 Million | -187.56 Million | -211.26 Million | -257.01 Million | -241.37 Million | -120.1 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.52 Million | -11.66 Million | -55.19 Million | -8.51 Million | -8.95 Million | -15.64 Million |
| Depreciation & Amortization | 1.55 Million | 1.53 Million | 4.25 Million | 1.41 Million | 937 Thousand | 924 Thousand |
| Deferred income taxes | -561 Thousand | -513 Thousand | 3.2 Million | 1.88 Million | 1000.00 | 1.32 Million |
| Stock-based compensation | 5.37 Million | 5.22 Million | 25.37 Million | 5.82 Million | 6.26 Million | 6.26 Million |
| Change in working capital | 2.69 Million | 4.11 Million | -8.34 Million | -3.41 Million | -1.34 Million | -5.87 Million |
| Other non-cash items | 11.17 Million | 5.57 Million | 3.7 Million | 1.94 Million | 609 Thousand | 568 Thousand |
| Investing Cash Flow | -3.03 Million | 17.02 Million | -32.69 Million | -677 Thousand | -21 Thousand | 11.04 Million |
| Investments in PPE | -36 Thousand | -91 Thousand | -2.48 Million | -677 Thousand | -21 Thousand | -852 Thousand |
| Acquisitions | - | - | 1.51 Million | -1.51 Million | - | 1.3 Million |
| Investment purchases | -31.23 Million | -26.9 Million | -134.53 Million | - | - | -1000.00 |
| Sales/Maturities of investments | 28.24 Million | 44.02 Million | 102.81 Million | - | - | 10.59 Million |
| Other Investing Activities | - | 17.11 Million | -30.2 Million | 1.51 Million | - | 11.89 Million |
| Financing Cash Flow | -44 Thousand | -1.71 Million | -198.93 Million | -30.6 Million | -31.4 Million | -80.68 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -463 Thousand | -1.71 Million | -199.55 Million | -30.78 Million | -31.4 Million | -81.12 Million |
| Common Stock Issuance | 44 Thousand | - | 618 Thousand | 618 Thousand | - | - |
| Other Financing Activities | 375 Thousand | -1.71 Million | -2.5 Million | -445 Thousand | -1000.00 | 446 Thousand |
| Accounts receivables | 365 Thousand | 2.81 Million | -689 Thousand | -417 Thousand | -1.26 Million | -3.52 Million |
| Accounts payables | -2000.00 | 184 Thousand | 6000.00 | -348 Thousand | 271 Thousand | -919 Thousand |
| Inventory | - | - | -8.54 Million | -4.78 Million | 1.26 Million | 3.52 Million |
| Other working capital | 2.32 Million | 1.12 Million | 886 Thousand | 2.13 Million | -1.61 Million | -4.95 Million |
| Cash at beginning of period | 53.83 Million | 39.54 Million | 299 Million | 72.52 Million | 106.43 Million | 188.5 Million |
| Cash at end of period | 46.34 Million | 53.83 Million | 40.38 Million | 40.38 Million | 72.52 Million | 106.43 Million |
| Capital Expenditure | -36 Thousand | -91 Thousand | -2.48 Million | -677 Thousand | -21 Thousand | -852 Thousand |
| Effect of forex changes on cash | - | - | - | -36.79 Million | 36.79 Million | - |
| Net cash flow / Change in cash | -7.49 Million | 14.29 Million | -258.62 Million | -32.14 Million | -33.91 Million | -82.06 Million |
| Free Cash Flow | -4.45 Million | -1.11 Million | -29.48 Million | -1.53 Million | -2.5 Million | -13.28 Million |
1373
KCO
ONFOW
DSKY
ROU
UPR